CS Paper Radar

Auditing evaluation artifacts and data leakage in large language model systems for rare disease diagnosis

Jian Yang, Peilin Liu, Xiaohan Li, Songda Li, Yu Cao, Yuqing Feng, Haomin Li

cs.AI ·submitted 2026-10-24 10:35 UTC · v1
benchmark

Abstract

Augmented large language model (LLM) systems have reported high benchmark accuracies in rare disease diagnosis, yet their real-world clinical utility remains unproven. A recent meta-analysis flagged augmented LLM diagnostic evaluations as having a high risk of bias due to suspected data leakage; however, the precise impact of these vulnerabilities on model inference has yet to be fully quantified. In this study, we present a comprehensive empirical audit to quantify evaluation artifacts across prevailing AI paradigms, using a repository of over 60,000 cases from diverse public and independent clinical cohorts. By reconstructing a state-of-the-art agentic framework, we demonstrate that candidate-space contamination artificially inflates performance: enforcing strict cross-dataset isolation resulted in a marked performance decline, with the cross-dataset mean Recall@1 decreasing from 54.3% (under conventional one-vs-rest evaluation) to 40.3% (Hedges' g = 0.94). Similar spatial overfitting in supervised classifiers caused diagnostic accuracy to drop from an internal mean of 42.9% to 16.7% across external cohorts (Cohen's d = 2.01). Furthermore, we quantify how LLMs infer diagnoses by exploiting retrospective therapeutic cues in clinical narratives, and how temporal misalignment in foundational knowledge bases leads to performance fluctuations. We conclude that prevailing evaluation protocols for augmented LLM systems inadvertently reflect data leakage rather than genuine medical reasoning. To address these systematic artifacts, we propose a rigorous evaluation framework - coupling strict data-isolation protocols with standardized benchmarking safeguards - to ensure future diagnostic AI for rare diseases is evaluated on actual clinical robustness.

Comment
18 page, 3 figures

Closest papers

Nearest neighbours by meaning across the whole index.

Memorisation bias in medical AI

cs.LG cs.CY ·2026-09-15 ·Moritz A. Knolle, Martin J. Menten, Laurin Lux, Mélanie Roschewitz, Emma A. M. Stanley +3 more
similarity 0.68
Abstract

Medical AI models hold immense potential to improve patient outcomes, but they are also known to unintentionally memorise individual records from their training datasets. While such memorisation has been linked to targeted privacy attacks, its consequences for clinical deployment, where patients may be assessed by a model that saw their historical data during training, remain poorly understood. Here we show that predictions on a patient's unseen future data can change significantly if a model observed that same patient's anonymised historical data during training, a phenomenon we term "memorisation bias". We demonstrate that this bias exists across diverse data modalities and model architectures, and over prolonged time spans: in some cases, memorisation bias persists on future records acquired decades after the historical records used for training. Moreover, in simulated prospective deployment, memorisation bias has asymmetric effects on the diagnostic accuracy of returning data contributors. When a patient returned with a de novo condition absent from their historical records in the training dataset, diagnostic sensitivity decreased significantly compared to an otherwise identical model not trained on their historical data. Conversely, when their health state was unchanged, both sensitivity and specificity were significantly inflated. Our findings reveal a previously uncharacterised risk in medical AI that arises when a model is deployed on patients who contributed to its training data. This exposes a shortcoming of current model development practice: the de-identification measures designed to protect patients' privacy make it difficult to identify returning contributors and exclude them from the AI-assisted interpretation of their own future data. Mitigating memorisation risks may thus require changes to current model training and deployment protocols.

0.18

Learning to Fuse LLMs with Ontology Rankers for Rare-Disease Diagnosis

cs.CL ·2026-09-02 ·Zhaoyang Jiang, Zhizhong Fu, Yunsoo Kim, Zicheng Li, Xuanqi Peng +3 more
benchmark similarity 0.67
Abstract

Ontology rankers remain useful for rare-disease diagnosis because each candidate can be traced to matched patient phenotypes. Large language models (LLMs) can generate differential diagnoses from the same patient description, but their predictions lack an equally clear evidence trail. Rather than asking which system should replace the other, we ask whether an LLM can improve the ranker without giving up its evidence. Our behavior-based fusion model examines the two ranked lists, their agreement, and the ontology support behind each candidate, and learns how much to rely on each system for the individual case. Before comparison, we remove a documented test-set leakage pathway caused by benchmark cases and ontology annotations being derived from the same publications. Across eight open LLMs, fusion improves Phenomizer Recall@1 by 7.86 percentage points on Phenopacket Store and 20.18 points on RAMEDIS. When paired with DeepSeek-V4-Flash through an API, a fusion model trained only on the other LLMs improves Recall@1 from 0.1657 to 0.2176, a 5.19-point gain, without retraining. For 90.8% of correct fused diagnoses, the disease retains candidate-level ontology evidence that can be inspected. These results show that LLMs can strengthen an established diagnostic tool without discarding the structured evidence that makes it useful.

0.16

Complementary Vulnerabilities: Auditing and Governing Clinician-LLM Error Overlap

cs.CY ·2026-10-18 ·Mohsen Amoei, Kathleen Fraser, Dan Poenaru
published similarity 0.67
Abstract · 4 pages main text, 2 figures. Accepted at SMASH 2026, the Symposium on Model Accountability, Sustainability and Healthcare (Mila, Montreal, …

Health systems are deploying large language models (LLMs) into clinical workflows, often on the assumption that a second automated check can only reduce error. But a second reasoner reduces error only insofar as it fails differently from the first. We say that a clinician and a model have complementary vulnerabilities to the extent that they break down through different mechanisms and on different cases. The two reasoners' failure substrates differ: they are embodied and cognitive in the clinician, and statistical and generative in the model - so their weak points need not line up. That divergence is plausible rather than guaranteed, and the independence it creates is fragile, eroding when clinicians defer to the model or the model conforms to the clinician. We therefore propose a predeployment audit in which each site measures error overlap on its own cases. We also propose a governance model with which the site keeps those errors independent over time. Health systems should then judge a clinical artificial intelligence (AI) tool by whether its failures overlap with their clinicians' failures, as well as by its accuracy.

0.37

Making Clinical Language Models Auditable: Concept-Guided Fine-Tuning for Robust Prediction

cs.CL cs.AI ·2026-08-27 ·Jin Mu, Guanhua Chen
top venue similarity 0.67
Abstract

Clinical language models can achieve strong in-hospital accuracy yet fail under deployment shifts because they exploit note-specific artifacts (e.g., templates, separators, boilerplate) that do not reflect patient state. We propose CAST (Concept-guided Artifact Suppression Tuning), an SAE-based framework for auditable clinical text classification. CAST uses Sparse Autoencoders to expose sparse, human-auditable features from intermediate Transformer activations, labels SAE latents with an LLM-assisted interpretation pipeline and ICD-10 retrieval constraints, suppresses verified artifact latents via residual subtraction during fine-tuning, and provides post-hoc per-concept attributions for auditing model decisions. On MIMIC-IV discharge-note mortality prediction, CAST improves over its corresponding fine-tuned encoder baselines and remains competitive with strong LLM baselines, while producing a feature-level audit trail of the clinical concepts that support each prediction and the artifact concepts suppressed during training.

0.44

OpenMTB-Audit: Exposing Over-Refusal and Clinical Expert Perspectives in LLM-Based Molecular Tumor Board Safety Evaluation

cs.AI cs.LG ·2026-10-01 ·Negin Ashrafi, Jia Luo, Stacey M. Frumm, Roxana Daneshjou
publishedbenchmarkcode/data similarity 0.66
Abstract · Accepted for oral presentation and publication at the Pacific Symposium on Biocomputing (PSB) 2027

Molecular tumor boards integrate genomic findings, clinical context, and therapeutic evidence to support precision oncology. As AI enters this workflow, a key safety challenge is distinguishing truly unsupported recommendations from evidence-supported options that still require oncologist review because of incomplete information, poor ECOG performance status, or other clinical caveats. We introduce OpenMTB-Audit, an open-source benchmark of 500 synthetic non-small cell lung cancer cases spanning five adversarial error categories and four safety labels: Supported, Partially Supported, Unsupported, and Insufficient Information. Across eight large language model configurations, we identify pervasive over-refusal: all LLM configurations failed to retain the Partially Supported label in 83.3-100% of true Partially Supported cases, achieving high aggregate safety scores through label collapse rather than clinically calibrated reasoning. To address this limitation, we developed MTB-AuditAgent, a deterministic seven-module framework separating evidence verification, missing-information detection, safety classification, and abstention. It reduces over-refusal to 6.7% and achieves 91.2% accuracy (95% CI: 88.6-93.6%). A two-oncologist annotation study found disagreement concentrated at the boundary between information sufficiency and treatment optimization, underscoring the need to preserve clinically meaningful distinctions.

0.35

Does Neural Complexity Improve Health Misinformation Detection? A Leakage-Controlled Cross-Corpus Benchmark

cs.CL cs.LG ·2026-10-03 ·Mkululi SIKOSANA
benchmarkcode/data similarity 0.66
Abstract · 18 pages, 3 tables. Reproducibility materials and source code are available from the author

Increasing architectural complexity is often assumed to improve health misinformation detection, yet reported gains are difficult to interpret when studies use different corpora, preprocessing pipelines, data splits, and leakage controls. This study provides a controlled cross-corpus benchmark of five compact neural architectures (1D-CNN, LSTM, BiLSTM, CNN-LSTM, and CNN-BiLSTM), a soft-voting neural ensemble, and three classical machine-learning baselines using COVID19-FNIR and CONSTRAINT. Exact-text duplicate controls were applied before modelling; all neural systems used a common preprocessing and optimisation protocol, and neural results were repeated across three random seeds. On COVID19-FNIR, the deep ensemble achieved a mean macro-F1 of 0.9963 and ROC-AUC of 0.9994, while individual neural models ranged from 0.9945 to 0.9957 macro-F1. On CONSTRAINT, the ensemble achieved macro-F1 of 0.9272 and ROC-AUC of 0.9811, whereas a linear SVM achieved macro-F1 of 0.9574 and ROC-AUC of 0.9931. Architecture rankings changed across corpora, and simple sparse linear models remained highly competitive. The findings show that model complexity does not provide a stable performance advantage and that benchmark construction can dominate architecture choice. The study contributes a reproducible, leakage-controlled basis for evidence-driven model selection in health misinformation classification

0.33

LeakBench: Auditing Reward Hacking through Prediction-Time Leakage in Clinical Modeling Agents

cs.CR cs.LG ·2026-10-19 ·Xiaoyuan Bao, Jingsi Jiang, Jiao Shan, Yulong Cao, Haoyu Wang +2 more
benchmark similarity 0.66
Abstract · 28 pages, 4 figures. LeakBench implementation code is not included in this arXiv version. Public companion software archives provide non-ide…

Autonomous clinical-modeling agents can optimize predictive performance while violating conditions that make a model usable. We introduce LeakBench, an executable, guideline-derived audit suite that tests agent decisions for prediction-time leakage, calibration, site-level evaluation, support awareness, and decision-curve net benefit. LeakBench combines a synthetic task with known failure structure and two real-data settings: MIMIC-IV (430k admissions) and governed multi-hospital inpatient record front-page (MHFP) data. Our primary analysis uses reward hacking descriptively, without attributing intent: an agent selects prediction-time-invalid inputs because they improve its validation reward. A deterministic optimizer and every evaluated unconstrained local-model configuration select a fatal leaking feature. In fully logged September 2026 A/B runs, DeepSeek Flash and GPT-6-astra each leak in 10/10 unconstrained runs and 0/10 runs with an explicit admission-time constraint. This contrast is version-sensitive: a blinded Claude/Fable-5.1 chat run does not leak in either condition, while explicit-constraint violations appear only in a historical August 2026 slice lacking raw trajectories. Replacing AUROC with AUPRC does not remove leakage selection. Renaming or disguising the leaking inputs changes neither selection nor provenance-based detection; a name-based filter fails. A deterministic provenance verifier-in-loop removes the leak, making the LLM repair loop defense-in-depth. Specific verifier feedback clears fatal leakage in a hosted agent, and a three-seed ablation finds principle-only feedback clears decision-level defects, though these mitigation results are limited. LeakBench treats trustworthy clinical prediction as a property of an agent's modeling process, not merely its score; it is an audit testbed with known-failure controls, not yet an expert-validated benchmark.

0.30

Toward Better Assessment of LLMs' Performance in Clinical Error Detection

cs.CL cs.AIcs.LG ·2026-08-17 ·Yifan Zhang, Rahmatollah Beheshti
top venuebenchmarkcode/data similarity 0.66
Abstract · Accepted at Machine Learning for Healthcare (MLHC) 2026; to appear in Proceedings of Machine Learning Research (PMLR), Vol. 340

Automated detection of errors in clinical documentation is a promising application of large language models (LLMs), yet decisions to deploy such models rest on benchmarks that evaluate each clinical note in isolation. Error-detection benchmarks are typically constructed by injecting errors into notes, such that each erroneous note has a natural counterpart. Aggregate discriminative metrics (e.g., balanced accuracy or F1) do not exploit this structure. We show that this omission is consequential. In particular, evaluating 15 diverse LLMs on 4 standardized clinical error-detection test sets across 3 languages, we find that 13 of 15 models fall below the level of random pairwise discrimination, even while achieving F1 scores that standard practice would read as moderate. We also observe that the underlying bias patterns differ across languages: the same model can default to "no error" on one language and over-flag errors on another. To diagnose where discrimination breaks down, we further introduce a procedure to score the evidence models cite in their outputs. We find that while models consistently locate error-relevant content, they fail to produce the corresponding correct verdict on the clean counterpart. Finally, we show that F1 and pairwise accuracy are driven in opposite directions by the same underlying bias, so that ranking models by F1 may systematically promote the weakest discriminators. For safety-critical clinical NLP applications, we advocate for supplementing aggregate metrics with paired evaluations in benchmark reporting. Code and analysis scripts are available at https://github.com/healthylaife/paired-clinical-eval.

0.58